HTLV-I and HTLV-II infections in volunteer blood donors and high-risk groups in Lebanon

Journal of Infection

Volumn 45, Issue 1, 2002, Pages 29-31

  Naman, R ^a   Klayme, S ^a   Naboulsi, M ^b   Mokhbat, J ^c   Jradi, O ^d   Ramia, S ^e  

^a SAINT JOSEPH UNIVERSITY   (Lebanon)

^b Islamic Hospital Tripoli   (Lebanon)

^c RIZK HOSPITAL   (Lebanon)

^d Labib Medical Center   (Lebanon)

^e AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; BLOOD DONOR; BLOOD TRANSFUSION; ENZYME IMMUNOASSAY; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS 2; HUMAN T CELL LEUKEMIA VIRUS INFECTION; LEBANON; POLYMERASE CHAIN REACTION; PREGNANCY; REVIEW; SCREENING; SEROLOGY; SEROPREVALENCE; VOLUNTEER; WESTERN BLOTTING;

EID: 0036665271     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1053/jinf.2002.1006     Document Type: Review

References (36)

1. Poiesz BJ, Ruscetti FW, Gazdar AF, Burn PA, Minna JD, Gallo RC. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proceedings of the National cutaneous T-cell lymphoma. Proc Natl Acad Sci USA 1980; 77: 7415-7419.
2. Hinuma Y, Komoda H, Chosa T, Kondo T, Kohakura M, Takenara T, Kicuchi M, Ichimaru M, Yunoki K, Sato I, Matsuo R, Takiuchi Y, Ughno H, Hanaoka M. Antibodies to adult T-cell leukemia virus associated antigen (ATLA) in sera from patients with ATL and controls in Japan: a nationwide seroepidemiological study. Inter J Cancer 1982; 29: 631-635.
3. Kuffler PR, Bunn PA Jr. Adult T-cell leukaemia/lymphoma. Clin Haematol 1986; 15: 595-726.
4. Gessain A. Barin F, Vernant JC, Gout O, Maurs L, Calender A, De The, G. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet 1985; 2: 407-410.
5. Gessain A, Gout O. Chronic myelopathy associated with human QJ;T-lymphotropic virus type-I (HTLV-I). Ann Intl Med 1992; 117: 933-946.
6. Willey CA, Nerenberg M, Cros D, Soto-Agular MC. HTLV-I polymyositis in a patient also infected with the human immunodeficiency virus. NEJM 1989; 320: 992-995.
7. Blattner WA. Epidemiology of HTLV-I and associated diseases. In: Blattner WA (ed.) Human Retrovirology: HTLV. London: Raven Press, 1990: pp. 251-266.
8. Loughran TP, Colyle T, Sherman MP. Detection of human T-cell leukemia/lymphoma virus, type II. in a patient with large granular lymphocyte leukemia. Blood 1992; 80: 1116-1119.
9. Huelle B, Arrenzeller O, Mills R, Alexander S, Torrez-Marinez N, Jainke R, Ross G. Chronic neurogenerative disease associated with HTLV-II infection. Lancet 1992; 339: 645-646.
10. Hanada S, Uematsu T. Iwahashi M, Nomura K, Utsunomiya A, Kodama M, Ishibashi K, Terada A, Saito T, Makino T, Uozumi K, Kuwazuru Y, Otsuka M, Harada R, Hashimoto S, Sakurami T. The prevalence of human T-cell leukemia virus type I infection in patients with hematologic and non-hematologic disease in an adult T-cell leukemia-endemic area of Japan. Cancer 1989; 64: 1290-1295.
11. Gibbs WN, Lofters WS, Campbell M, Hanchard B, La Grenade L, Granston B, Hendriks J, Jaffe ES, Saxinger C, Robert-Guraff M, Callo RC, Clark J, Blatner WA. Non-Hodgkin lymphoma in Jamaica and its relation to adult T-cell leukemia-Lymphoma. Ann Int Med 1987; 106: 361-368.
12. Reeves WC, Levine PH, Cuevas M, Quiroz E, Maloney E, Saxinger WC. Seroepidemiology of human T-cell lymphotropic virus in the Republic of Panama. Am J Trop Med Hyg 1992; 42: 374-379.
13. Maloney EM, Biggar RJ, Neel JV, Taylor ME, Hahn BH, Shaw GM, Blattner WA. Endemic human T-cell lymphotropic virus type II infection among isolated Brazilian Amerindians. J Infect Dis 1992; 166: 100-107.
14. Delaporte E, Peeters M, Durand JP, Dupont A, Schrijvers D, Bedjabaga L, Honore C, Ossari S, Trebucq A, Josse R. Seroepidemiological survey of HTLV-I infection among randomized populations of western central African countries. J Acquir Immune Defic Syndr 1989; 2: 410-413.
15. Yanagihara R, Jenkins CL, Alexander SS, Mora CA, Garruto RM. Human T-lymphotropic virus the I infection in Papua, New Guinea: high prevalence among the Hagahai confirmed by western analysis. J Infect Dis 1990; 162: 649-654.
16. Bastian I, Gardner J, Webb D, Gardner I. Isolation of a human T-lymphotropic virus type-I strain from Australian aboriginals. J Virol 1993; 67: 843-851.
17. Monplaisir N, Nelsson-Vernant C, Bouillot M, Duc-Dodon M, Ugarte E, Valette I, Dezaphy Y, Ouka M, Eudaric MG, Gazzolo L, Larouze B, D'auriol L. HTLV-I maternal transmission in Martinique, using serology and polymerase chain reaction. AIDS Res Hum Retrovirus 1993: 9: 869-974.
18. Sullivan MT, Williams AE, Fang CT, Notari EP, Poiesz BJ, Ehrlich GD. Human T-lymphotropic virus (HTLV) types I and II infection in sexual contacts of family members of blood donors who are seropositive for HTLV type I or II. Transfusion 1993; 33: 585-590.
19. Blomberg J, Moestrup T, Frimand J, Hansson BG, Krogsgaard K, Grillner L, Nordenfelt E. HTLV-I and II in intravenous drug users from Sweden and Denmark. Scan J Infect Dis 1994; 26: 23-26.
20. Kleinman S, Swanson P, Allain JP, Lee H. Transfusion transmission of human T-lymphotropic virus types I and II: serologic and polymerase chain reaction results in recipients identified through look-back investigations. Transfusion 1993; 33: 14-18.
21. Soriano V, Calderon E, Esparza B, Cilla G, Aguilera A, Gutierrez M, Tor J, Pujol E, Merino F, Perez-Trallero E, Leal M, Gonzalez-Lahoz J. HTLV-I/II infections in Spain. The HTLV-I/II Spanish Study Group. Int J Epidemiol 1993; 22: 716-719.
22. Kamihira S, Nakasima S, Oyakawa Y, Moriuti Y, Lchimaru M, Okuda H, Kanamura M, Oota T. Transmission of human T-cell lymphotropic virus type I by blood transfusion before and after mass screening of sera from seropositive donors. Vox Sang 1987; 52: 43-44.
23. Meytes D, Schochat B, Lee H, Nadel G, Sidi Y, Cerney M, Swanson P, Shaklai M, Kilim Y, Elgat M, Chin E, Donon Y, Rosenblatt J. Serological and Molecular survey for HTLV-I infection in high-risk Middle Eastern group. Lancet 1990; 336: 1533-1535.
24. Khabbaz RF, Heneine E, Grindon A, Hartley TM, Siluman G, Kaplan J. Indeterminate HTLV serologic results in U.S. Blood Donors: Are they Due to HTLV-I or HTLV-II? J Acquir Immune Defic Syndr 1992; 5: 400-404.
25. Manns A, Murphy EL, Wilks RJ, Haynes G, Figueroa JP, Manchard B, Palker JJ, Blatner WA. Early antibody profile during HTLV-I sero-conversion (letter). Lancet 1991; 337: 181-182.
26. Araj G, Kfoury-Baz E, Barada K, Nassif R, Alami S. Hepatitis C virus: prevalence in Lebanese blood donors and brief overview of the disease. J Med Lebanis 1995; 43: 11-16.
27. Nassar NT, Alami SY, Nasrallah SM, Alam CK. The prevalance of hepatitis B surface antigen (HbsAg) among students and blood donors at the American University of Beirut (AUB). The Johns Hopkins Med J 1996; 139: 45-48.
28. Naman R, Mokhbat J, Abdelnoor A, Irani-Hakimeh N, Alami S, Nassif R. Seroepidemiology of the human immunodefeciency virus-infections in Lebanon. Lebanese Sci Bull 1989; 5: 9-14.
29. Mattar GM, Traboulsi RA, Abdelnoor AM, Oseiran M. Serosurvey of HTLV-I/II in a selected population in Lebanon. Rev Med Libanaise 1996; 8: 23-24.
30. Courouce AM, Pillonel J, Lemaire JM. HTLV-I and HTLV-II infections in French blood donors (letter). Vox Sang 1993; 65: 334.
31. Soriano V, Gutierrez M, Esparza B et al. HTLV-I and HTLV-II infections in Spain (letter). Vox Sang 1993; 64: 59-60.
32. Dlekos GN, Zerrou E, Karabini F, Elisaf M, Bourantask, Siamopoulos KC. Prevalence of antibodies to human T-Lymphotropic virus types I and II in volunteer blood donors and high-risk groups in northwestern Greece. Transfusion 1995; 35: 503-506.
33. Arif M, Ramia S. Seroprevalence of human T-lymphotropic virus type I (HTLV-I) in Saudi Arabia. Ann Trop Med Parasitol 1998; 92: 305-309.
34. Constantine NT, Fathi Sheba M, Corwin AL, Danahy RS, Callahan JD, Watts DM. A serosurvey for HTLV-I among high-risk populations and normal adults in Egypt. Epidermiol Infect 1991; 107: 429-433.
35. Al-Mufti S, Voevodin A, Ahmed S, Al-Hamdan S, Al-Bisher AA. Prevalence of human T-cell lymphotropic virus type I infection among volunteer blood donors in Kuwait. J Acquir Immune Defic Syndr Hum Retrovirol 1997; 15: 88-90.
36. Knox-Macaulary H, McDonald R, al-Busaidy S, Ali N. HTLV-I seroprevalence in the Sultanate of Oman. Scand J Infect Dis 1997; 29: 217-218.